Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Underweight on Moelis, Lowers Price Target to $38

Author: Benzinga Newsdesk | November 03, 2023 09:03am
Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:MC) with a Underweight and lowers the price target from $39 to $38.

Posted In: MC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist